Sculptor Capital’s Medicines Co MDCO Stock Holding History

Sculptor Capital’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-385,284	Closed	-$10.8M	–	501
2015 Q1	$10.8M	Buy	+385,284	New	+$10.8M	0.04%	217

Other funds holding MDCO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sculptor Capital's MDCO Position: Q2 2015 in Review

Sculptor Capital sold out of Medicines Co (MDCO) in Q2 2015, closing a stake of 385,284 shares — an estimated $10.8M sold.

Sculptor Capital first reported a position in MDCO in Q1 2015 and held it in 1 quarter. The position peaked at $10.8M in Q1 2015. 172 funds tracked by Wall St. Rank hold MDCO as of Q2 2015.

Sculptor Capital reported no remaining Medicines Co position as of Q2 2015 after selling out during the quarter.
Sculptor Capital sold 385,284 Medicines Co shares in Q2 2015, an estimated $10.8M.
Sculptor Capital first reported a position in Medicines Co in Q1 2015 and held it in 1 quarter.
Sculptor Capital's Medicines Co position peaked at $10.8M in Q1 2015.
172 funds tracked by Wall St. Rank held Medicines Co as of Q2 2015.

Based on Sculptor Capital's 13F filing for Q2 2015, filed 14 Aug 2015.